Read the Immuno-Oncology Insights interview with BreakBio’s CEO Roy de Souza and CTO David Hawke here:

https://www.insights.bio/immuno-oncology-insights/journal/article/3153/Revolutionizing-cancer-treatment-A-conversation-on-the-potential-of-personalized-cancer-vaccines